Pediatric Cardiology Unit, Department of Pediatrics-Parma University Hospital, via Gramsci 14 Parma, Italy.
Clin Cardiol. 2009 Nov;32(11):E71-4. doi: 10.1002/clc.20674.
Transcatheter closure is the preferred method of treatment of patent ductus arteriosus (PDA). Detachable coils are widely used to close small ducts, while the Amplatzer duct occluder (ADO) is generally employed for moderate or large ducts. Recently a new device, the Amplatzer duct occluder II (ADO II), a nitinol flexible mesh, with a symmetrical design to provide high conformability for treatment of all types of PDA, has received the European Community mark approval. We report on one of the first experience, four cases (1 male, 3 female, age ranging from six months to seven years old) with different type and size of PDA treated with the new device. The use of this new Amplatzer duct occluder in our experience has the advantage of ease and safety of placement, conformability, stability, low profile catheters, adaptability for long ducts as in type E.
经导管封堵术是动脉导管未闭(PDA)的首选治疗方法。可解脱弹簧圈被广泛用于封堵小的动脉导管,而 Amplatzer 动脉导管封堵器(ADO)通常用于中等或大的动脉导管。最近,一种新型装置——Amplatzer 动脉导管封堵器 II(ADO II),一种镍钛诺柔性网,具有对称设计,可提供高度顺应性,用于治疗所有类型的 PDA,已获得欧洲共同体标志批准。我们报告了首批经验之一,4 例(1 例男性,3 例女性,年龄从 6 个月到 7 岁)不同类型和大小的 PDA 使用新型装置治疗的情况。在我们的经验中,使用这种新型 Amplatzer 动脉导管封堵器的优点是放置的简便和安全性、顺应性、稳定性、低剖面导管、对 E 型等长导管的适应性。